Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
27 févr. 2024 07h45 HE
|
Profound Medical Corp.
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
15 févr. 2024 16h30 HE
|
Profound Medical Corp.
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Non-Brokered Private Placement
16 janv. 2024 16h30 HE
|
Profound Medical Corp.
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) ("Profound" or the "Company") is pleased to announce that the Company has entered into subscription...
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
03 janv. 2024 16h15 HE
|
Profound Medical Corp.
TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
27 déc. 2023 22h40 HE
|
Profound Medical Corp.
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) today announced the pricing of its previously announced underwritten public...
Profound Medical Announces Proposed Public Offering of Common Shares
27 déc. 2023 16h15 HE
|
Profound Medical Corp.
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) is pleased to announce the commencement of an underwritten public offering in...
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
08 nov. 2023 07h45 HE
|
Profound Medical Corp.
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
03 nov. 2023 08h00 HE
|
Profound Medical Corp.
TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Third Quarter 2023 Financial Results
02 nov. 2023 16h05 HE
|
Profound Medical Corp.
TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
19 oct. 2023 16h30 HE
|
Profound Medical Corp.
TORONTO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...